DAGNA, LORENZO
 Distribuzione geografica
Continente #
EU - Europa 13.142
AS - Asia 9.605
NA - Nord America 8.913
SA - Sud America 2.167
AF - Africa 224
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 12
AN - Antartide 1
Totale 34.102
Nazione #
US - Stati Uniti d'America 8.506
RU - Federazione Russa 7.046
SG - Singapore 3.488
CN - Cina 3.099
BR - Brasile 1.765
IT - Italia 1.331
RO - Romania 1.137
SE - Svezia 1.134
HK - Hong Kong 1.084
VN - Vietnam 895
DE - Germania 638
FR - Francia 506
GB - Regno Unito 383
IN - India 237
FI - Finlandia 235
CA - Canada 204
AR - Argentina 175
NL - Olanda 152
MX - Messico 137
AT - Austria 115
PL - Polonia 115
JP - Giappone 108
TR - Turchia 99
BD - Bangladesh 94
ZA - Sudafrica 92
ES - Italia 81
ID - Indonesia 81
IQ - Iraq 67
EC - Ecuador 56
IE - Irlanda 54
PK - Pakistan 53
CO - Colombia 45
PH - Filippine 44
LT - Lituania 39
UA - Ucraina 39
VE - Venezuela 36
MA - Marocco 34
SA - Arabia Saudita 30
AU - Australia 29
PY - Paraguay 27
UZ - Uzbekistan 27
PE - Perù 25
AE - Emirati Arabi Uniti 22
CL - Cile 22
IL - Israele 22
BE - Belgio 21
EG - Egitto 21
IR - Iran 19
KE - Kenya 19
TN - Tunisia 19
JO - Giordania 18
MY - Malesia 17
DO - Repubblica Dominicana 14
HN - Honduras 13
NO - Norvegia 13
NP - Nepal 12
CH - Svizzera 11
UY - Uruguay 11
AZ - Azerbaigian 10
DZ - Algeria 10
GR - Grecia 10
PT - Portogallo 10
BG - Bulgaria 9
BH - Bahrain 8
KZ - Kazakistan 8
NZ - Nuova Zelanda 8
SN - Senegal 8
CZ - Repubblica Ceca 7
JM - Giamaica 7
KR - Corea 7
TH - Thailandia 7
XK - ???statistics.table.value.countryCode.XK??? 7
DK - Danimarca 6
LV - Lettonia 6
MD - Moldavia 6
PA - Panama 6
TW - Taiwan 6
BW - Botswana 5
EU - Europa 5
GE - Georgia 5
HU - Ungheria 5
LU - Lussemburgo 5
MK - Macedonia 5
NI - Nicaragua 5
BO - Bolivia 4
BY - Bielorussia 4
GT - Guatemala 4
LB - Libano 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
CY - Cipro 3
ET - Etiopia 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
MO - Macao, regione amministrativa speciale della Cina 3
PS - Palestinian Territory 3
QA - Qatar 3
SY - Repubblica araba siriana 3
Totale 34.051
Città #
Dallas 2.463
Singapore 1.746
Moscow 1.399
Ashburn 1.131
Hong Kong 1.061
San Jose 850
Shanghai 654
Beijing 444
Hefei 436
New York 410
Lauterbourg 374
Milan 361
Ho Chi Minh City 326
Lawrence 278
Princeton 278
Los Angeles 257
Munich 197
Hanoi 191
Boardman 185
São Paulo 177
Nuremberg 152
Helsinki 128
Rome 109
Orem 107
Santa Clara 98
Warsaw 92
Denver 86
London 83
Montreal 83
Tokyo 74
Guangzhou 69
Poplar 69
Rio de Janeiro 69
Brooklyn 66
Atlanta 62
Chennai 62
Frankfurt am Main 62
Johannesburg 61
Turku 54
Amsterdam 52
Chicago 51
Lappeenranta 49
Mexico City 49
Council Bluffs 48
Dublin 48
Seattle 48
Houston 46
Phoenix 46
Stockholm 46
Manchester 44
Boston 43
Pune 43
Ankara 42
Toronto 42
Vienna 42
Washington 38
Belo Horizonte 35
Da Nang 35
Mumbai 34
Falkenstein 33
Haiphong 33
Brasília 30
Cesano Boscone 30
Querétaro 26
Tianjin 25
Tashkent 24
Xi'an 24
Ancona 23
Buffalo 23
Curitiba 23
Istanbul 23
Shenzhen 23
The Dalles 23
Jakarta 22
Lahore 22
New Delhi 21
Salvador 21
Campinas 20
Hải Dương 20
Cape Town 19
Florence 19
Porto Alegre 19
San Francisco 19
Turin 19
Baghdad 18
City of London 18
Genoa 18
Bexley 17
Biên Hòa 17
Brussels 17
Paris 17
Wolfhagen 17
Amman 16
Bologna 16
Columbus 16
Guayaquil 16
Buenos Aires 15
Jiaxing 15
Nairobi 15
Rotterdam 15
Totale 16.532
Nome #
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study 568
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 453
Intercalated Disc Abnormalities Are Linked to Arrhythmias in Inflammatory Cardiomyopathy 423
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 373
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 344
The association between body mass index and fibromyalgia severity: Data from a cross-sectional survey of 2339 patients 330
Monkeypox in a patient with undifferentiated connective tissue disease 249
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 229
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 203
Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination 203
EA4HP24-LYWS-293 An indolent EBV-related clonal T-cell proliferation presenting as chronic rhinosinusitis 185
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 180
A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients 177
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 166
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 166
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 164
Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study 159
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 154
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 152
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 151
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 148
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 146
Biobanking for COVID-19 research 144
Virus-encoded chemokines, chemokine receptors and chemokine-binding proteins: new paradigms for future therapy 143
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 142
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 141
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 141
Two-year multidisciplinary follow-up of COVID-19 patients requiring invasive and noninvasive respiratory support 140
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 137
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 133
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 128
Anakinra for patients with COVID-19: an updated systematic review and meta-analysis 126
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 125
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 124
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 123
Angiotensin II infusion and markers of organ function in invasively ventilated COVID-19 patients 123
Anifrolumab for Moderate and Severe Muco-Cutaneous Lupus Erythematosus: A Monocentric Experience and Review of the Current Literature 122
A bitter effect: thrombocytopenia induced by a quinidine-containing beverage 121
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 120
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 120
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation 120
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM) 119
Pentraxin-3 as a Marker of Disease Activity in Takayasu Arteritis 118
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 118
Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees 117
[Cardiovascular involvement in Erdheim-Chester syndrome: clinical and therapeutic implications]. FT Coinvolgimento cardiovascolare nella sindrome di Erdheim-Chester: aspetti clinici e terapeutici. 117
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 117
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 116
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias 115
Prone positioning in awake COVID-19 patients: a systematic review and meta-analysis 115
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 115
Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation 115
Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study 115
3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target 114
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 114
A Novel Histiocytosis With Synovial and Skin Involvement 114
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 114
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 113
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 113
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 112
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction 112
Exercise Stress Test Late after Arrhythmic versus Nonarrhythmic Presentation of Myocarditis 111
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 110
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 110
Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: The Role of Endomyocardial Biopsy 110
Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease 109
C3-glomerulopathy and MGUS: The skin beyond the kidney 108
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 108
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life 107
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study 107
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort 106
Allergy and dimethyl fumarate treatment in a patient with multiple sclerosis 106
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 105
Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series 105
Two months quality of life of COVID-19 invasively ventilated survivors; an Italian single-center study 105
Therapeutic strategies for primary heart involvement in systemic sclerosis 104
Igg4-related disease of the oral cavity. Case series from a large single-center cohort of italian patients 104
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis 103
Testosterone in males with COVID-19: A twelve-month cohort study 103
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 103
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 103
Cardiac Safety of mRNA-based Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Disorders with a History of Myocarditis 103
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients 103
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis 102
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 102
Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands 101
Assessing the role of pentraxin-3 in Takayasu's arteritis. Comment on: Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up. Alibaz-Oner F. et al 101
Drug retention rates of biological agents in adult onset Still's disease 101
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases 101
A relapsing inflammatory syndrome and HHV-8 100
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 99
Association of IgG4-related disease and systemic rheumatic disorders 99
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis 99
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 99
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry 98
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 98
Inflammation as a Predictor of Recurrent Ventricular Tachycardia After Ablation in Patients With Myocarditis 98
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 98
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies 98
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 98
Totale 14.124
Categoria #
all - tutte 177.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 177.537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 0 0 0 4 13 4
2021/2022431 3 0 101 78 26 27 33 26 42 37 30 28
2022/20232.175 652 435 141 21 36 244 220 209 102 39 40 36
2023/20242.244 79 135 231 200 184 373 118 204 18 92 210 400
2024/20257.670 639 146 220 243 291 550 2.019 711 1.014 686 486 665
2025/202622.179 1.583 2.171 2.331 2.866 1.780 662 2.025 1.662 6.132 967 0 0
Totale 34.927